Effects of adding dexmedetomidine to ropivacaine for paravertebral block in breast cancer surgery
European Journal of Molecular & Clinical Medicine,
2022, Volume 9, Issue 5, Pages 210-218
AbstractBackground: Effective pain control after surgery is an important part of taking care of someone who has had surgery. A paravertebral block (PVB) is becoming more popular for breast surgery and is thought to be the best method for anaesthesia and pain relief after surgery. Several local and regional anaesthetic techniques were looked at to see if they could reduce post-surgery pain after breast surgery. The thoracic PVB technique looks promising because it reduces post-surgery pain, reduces opioid use, reduces side effects like drowsiness and the risk of breathing problems, and saves money. The goal of this study was to find out how well dexmedetomidine works with ropivacaine as a paravertebral block in breast cancer surgery.
Material and Methods: Randomly, 100 women having breast surgery were split into two groups, Group PR and Group PRD. For thoracic paravertebral block, Group PR got 0.5% ropivacaine (0.3 ml/kg) with 1 ml normal saline, while Group PRD got the same amount of ropivacaine with 1 mcg/ml of dexmedetomidine. The groups were watched to see how well the block worked, how the hemodynamic parameters changed at different times, when the sensory block started, how long it lasted and if there were any complications during or after the surgery.
Results: When added to ropivacaine in TPVB as an adjuvant, dexmedetomidine gives good pain relief during and after surgery and reduces the need for painkillers after surgery. There were no problems with the technique or the way the blood flowed and there were no bad effects from the dexmedetomidine.
Conclusion: TPVB with ropivacaine and dexmedetomidine as an add-on can be a better choice for good pain relief and stable blood flow during breast surgery without complications or side effects.
- Article View: 2
- PDF Download: 8